Clinical Trials Browser

Phase 1 × Leukemia, Lymphocytic, Chronic, B-Cell × CYC065 × Clear all

NCT03739554 2024-01-25

CYC065 CDK Inhibitor and Venetoclax Study in Relapsed/Refractory CLL

Phase 1 Completed

LymphoidOther hematologic neoplasm

Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell